The Japanese Journal of Veterinary Dermatology
Online ISSN : 1881-2236
Print ISSN : 1347-6416
ISSN-L : 1347-6416
Volume 11, Issue 4
Displaying 1-6 of 6 articles from this issue
Originals
  • Toshihide Suenobu, Hidemi Shimoji, Masakatsu Sato
    2005 Volume 11 Issue 4 Pages 177-187
    Published: 2005
    Released on J-STAGE: October 27, 2006
    JOURNAL FREE ACCESS
    We performed clinical experience investigation on safety and efficacy of MIMIENA®, a pimaricin otic suspension for canine otitis externa. The investigation on safety was to survey mainly a trend of adverse drug reactions (ADRs). The efficacy of MIMIENA® evaluated in this study including the anti-fungal activity of that against M. pachydermatis as a causative agent of otitis externa was compared with the result in clinical trial before approval. Among 644 dog cases collected for the safety evaluation, 555 cases and 82 cases were used for the efficacy evaluation and for comparison of efficacy between the result in this investigation and that in the clinical trial before approval, respectively. ADRs were observed 2 of 644 cases (0.31%) and were redness or pruritis at the local application sites. The frequency of ADRs in this investigation was not significantly different from that in the clinical trial before approval in which no ADRs were observed in 145 cases. The efficacy rate in 555 cases in this investigation was 74.1% and that in 82 cases was 73.2%, which was comparable with the efficacy rate in 65 cases in the clinical trial (73.9%). These results indicated that the efficacy of the medicine did not significantly change after marketing. We suspected the reason of the unchanged efficacy that the anti-fungal activity against causative agents of otitis externa might have been well maintained because MIC90 against M. pachydermatis was 6.25 μg/ml and 4.0 μg/ml in approval result and in this study, respectively.
    Download PDF (308K)
  • Masato FUJIMURA, Masashiro SAKAGUCHI
    2005 Volume 11 Issue 4 Pages 189-192
    Published: 2005
    Released on J-STAGE: October 27, 2006
    JOURNAL FREE ACCESS
    We compared results of intradermal skin test with those of three commercially available IgE tests in dogs with atopic dermatitis. The results of intradermal skin tests and allergen-specific IgE tests were obtained in a total of 45 dogs with atopic dermatitis, of which 15 cases were tested in one company. Six common allergens (house dust mites, aspergillus, Bermuda grass, flea, ragweed short, plantein english) were examined for evaluation in allergen-specific IgE and intradermal skin tests. There were significant relationships between the results of skin and IgE tests (H company p<0.0001, G company p=0.0254, and S company p=0.0151).
    Download PDF (611K)
Case Reports
Brief Note
  • Kai Sonoda, Sanae Hayashiya, Makio Hayashiya, Atsuhiko Hasegawa
    2005 Volume 11 Issue 4 Pages 199-204
    Published: 2005
    Released on J-STAGE: October 27, 2006
    JOURNAL FREE ACCESS
    The diseases observed in 543 canine cases presented at an animal hospital in Tokyo from April 2002 to September 2004 were investigated. Skin diseases were seen in 41.1% of the cases (223 cases) including 109 cases of allergic dermatitis (20.1%). Among 109 cases with allergic skin disease, 59 cases (54.1%) were of atopic dermatitis and/or food allergy. These results were consistent with those reported in Europe and USA including breed predisposition.
    Download PDF (226K)
Letters
feedback
Top